Niagen Bioscience Inc
NAGE | NASDAQ
$3.06
+$0.02 (+0.66%)
Sep 22, 2026, 11:27 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Net Income | 17.38M | 8.55M | -4.94M | -16.54M | -27.13M | -19.93M |
Depreciation & Amortization | 1.45M | 1.48M | 1.71M | 1.88M | 1.63M | 1.51M |
Stock-Based Compensation | 6.07M | 3.66M | 4.75M | 5.74M | 6.2M | 6.94M |
Other Working Capital | 1.83M | 147K | 1.66M | -875K | -1.21M | 1.96M |
Other Non-Cash Items | -3.17M | -4.72M | 977K | -167K | -124K | -204K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -8.3M | 3.13M | 4.62M | -6.01M | -4.73M | 1.08M |
Operating Cash Flow | 13.44M | 12.11M | 7.12M | -15.1M | -24.16M | -10.6M |
Capital Expenditures | -292K | -163K | -148K | -334K | -409K | -142K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 20K | 5K | n/a | n/a | -41K |
Investing Cash Flow | -292K | -143K | -143K | -334K | -409K | -165K |
Debt Repayment | -12K | -11K | -15K | -16K | -31K | -272K |
Common Stock Repurchased | -251K | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -52K | -75K | -77K | 9.39M | 4.07M |
Financial Cash Flow | 6.98M | 5.37M | -90K | 7.65M | 36.09M | 8.65M |
Net Cash Flow | 20.13M | 17.34M | 6.88M | -7.78M | 11.52M | -2.12M |
Free Cash Flow | 13.15M | 11.95M | 6.97M | -15.43M | -24.57M | -10.74M |
Adj. Free Cash Flow | 7.08M | 8.29M | 2.22M | -21.17M | -30.77M | -17.68M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | -292K | -163K | -148K | -334K | -409K | -142K |
Owner Earnings | 13.44M | 12.11M | 7.12M | -15.1M | -24.16M | -10.6M |
Add to Watchlist
Select watchlists to add or remove NAGE